BOC Fundamental Analysis - BOSTON OMAHA CORP-CL A

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to BOC. BOC was compared to 91 industry peers in the Media industry. The financial health of BOC is average, but there are quite some concerns on its profitability. BOC is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

BOC had negative earnings in the past year.

BOC had a positive operating cash flow in the past year.

In multiple years BOC reported negative net income over the last 5 years.

Of the past 5 years BOC 4 years had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -0.03%, BOC is in the better half of the industry, outperforming 61.54% of the companies in the same industry.

The Return On Equity of BOC (-0.04%) is better than 62.64% of its industry peers.

		Industry Rank	Sector Rank
ROA	-0.03%
ROE	-0.04%
ROIC	N/A

ROA(3y)-0.02%

ROA(5y)1.3%

ROE(3y)-0.04%

ROE(5y)2.1%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

BOC has a better Gross Margin (67.24%) than 81.32% of its industry peers.

BOC's Gross Margin has declined in the last couple of years.

The Profit Margin and Operating Margin are not available for BOC so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	67.24%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.45%

GM growth 5Y-1.7%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

BOC does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, BOC has about the same amount of shares outstanding.

Compared to 5 years ago, BOC has more shares outstanding

BOC has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 1.45, we must say that BOC is in the distress zone and has some risk of bankruptcy.

With a decent Altman-Z score value of 1.45, BOC is doing good in the industry, outperforming 65.93% of the companies in the same industry.

BOC has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.

BOC has a Debt to Equity ratio of 0.08. This is in the better half of the industry: BOC outperforms 75.82% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.08
Debt/FCF	N/A
Altman-Z	1.45

ROIC/WACCN/A

WACC8.41%

2.3 Liquidity

A Current Ratio of 2.07 indicates that BOC has no problem at all paying its short term obligations.

Looking at the Current ratio, with a value of 2.07, BOC is in the better half of the industry, outperforming 76.92% of the companies in the same industry.

A Quick Ratio of 2.07 indicates that BOC has no problem at all paying its short term obligations.

BOC has a Quick ratio of 2.07. This is in the better half of the industry: BOC outperforms 79.12% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.07
Quick Ratio	2.07

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 100.00% over the past year.

Looking at the last year, BOC shows a small growth in Revenue. The Revenue has grown by 6.92% in the last year.

The Revenue has been growing by 21.21% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)100%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-60%

Revenue 1Y (TTM)6.92%

Revenue growth 3Y23.87%

Revenue growth 5Y21.21%

Sales Q2Q%3.73%

3.2 Future

The Earnings Per Share is expected to decrease by -42.13% on average over the next years. This is quite bad

The Revenue is expected to grow by 4.54% on average over the next years.

EPS Next Y-430.25%

EPS Next 2Y-42.13%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year5.05%

Revenue Next 2Y4.54%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Forward Price/Earnings Ratio is negative for BOC. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BOC is on the same level as its industry peers.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	13.34

4.3 Compensation for Growth

A cheap valuation may be justified as BOC's earnings are expected to decrease with -42.13% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-42.13%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

BOC does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

BOSTON OMAHA CORP-CL A

NYSE:BOC (1/5/2026, 8:11:27 PM)

After market: 12.53 0 (0%)

12.53

-0.05 (-0.4%)

Chartmill FA Rating

GICS SectorCommunication Services

GICS IndustryGroupMedia & Entertainment

GICS IndustryMedia

Earnings (Last)11-13 2025-11-13/amc

Earnings (Next)03-26 2026-03-26/amc

Inst Owners69.48%

Inst Owner ChangeN/A

Ins Owners3.94%

Ins Owner Change0.78%

Market Cap394.07M

Revenue(TTM)112.60M

Net Income(TTM)-231.30K

Analysts76.67

Price Target14.28 (13.97%)

Short Float %5.01%

Short Ratio8.27

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)0

Avg EPS beat(2)-273.93%

Min EPS beat(2)-331.02%

Max EPS beat(2)-216.83%

EPS beat(4)1

Avg EPS beat(4)23.93%

Min EPS beat(4)-331.02%

Max EPS beat(4)941.58%

EPS beat(8)1

Avg EPS beat(8)-103.94%

EPS beat(12)3

Avg EPS beat(12)320.2%

EPS beat(16)3

Avg EPS beat(16)-316.28%

Revenue beat(2)0

Avg Revenue beat(2)-3.2%

Min Revenue beat(2)-5.02%

Max Revenue beat(2)-1.39%

Revenue beat(4)2

Avg Revenue beat(4)-1.13%

Min Revenue beat(4)-5.02%

Max Revenue beat(4)1.31%

Revenue beat(8)4

Avg Revenue beat(8)-0.6%

Revenue beat(12)7

Avg Revenue beat(12)0.23%

Revenue beat(16)9

Avg Revenue beat(16)0.79%

PT rev (1m)-22.22%

PT rev (3m)-22.22%

EPS NQ rev (1m)25%

EPS NQ rev (3m)-50%

EPS NY rev (1m)-2.44%

EPS NY rev (3m)-50%

Revenue NQ rev (1m)-0.86%

Revenue NQ rev (3m)-0.52%

Revenue NY rev (1m)-0.22%

Revenue NY rev (3m)-1.6%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	3.5
P/FCF	N/A
P/OCF	18.51
P/B	0.75
P/tB	1.35
EV/EBITDA	13.34

EPS(TTM)0

EYN/A

EPS(NY)-0.08

Fwd EYN/A

FCF(TTM)-0.21

FCFYN/A

OCF(TTM)0.68

OCFY5.4%

SpS3.58

BVpS16.8

TBVpS9.31

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-0.03%
ROE	-0.04%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	67.24%
FCFM	N/A

ROA(3y)-0.02%

ROA(5y)1.3%

ROE(3y)-0.04%

ROE(5y)2.1%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.45%

GM growth 5Y-1.7%

F-Score4

Asset Turnover0.16

Health

		Industry Rank	Sector Rank
Debt/Equity	0.08
Debt/FCF	N/A
Debt/EBITDA	2.01
Cap/Depr	108.95%
Cap/Sales	24.67%
Interest Coverage	N/A
Cash Conversion	95.49%
Profit Quality	N/A
Current Ratio	2.07
Quick Ratio	2.07
Altman-Z	1.45

F-Score4

WACC8.41%

ROIC/WACCN/A

Cap/Depr(3y)225.08%

Cap/Depr(5y)197.89%

Cap/Sales(3y)44.31%

Cap/Sales(5y)37.71%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)100%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-60%

EPS Next Y-430.25%

EPS Next 2Y-42.13%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)6.92%

Revenue growth 3Y23.87%

Revenue growth 5Y21.21%

Sales Q2Q%3.73%

Revenue Next Year5.05%

Revenue Next 2Y4.54%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y65.46%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year401.41%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y82.12%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y27.88%

OCF growth 3Y39.83%

OCF growth 5Y17.19%

BOSTON OMAHA CORP-CL A / BOC FAQ

What is the ChartMill fundamental rating of BOSTON OMAHA CORP-CL A (BOC) stock?

ChartMill assigns a fundamental rating of 3 / 10 to BOC.

What is the valuation status for BOC stock?

ChartMill assigns a valuation rating of 0 / 10 to BOSTON OMAHA CORP-CL A (BOC). This can be considered as Overvalued.

What is the profitability of BOC stock?

BOSTON OMAHA CORP-CL A (BOC) has a profitability rating of 3 / 10.

Can you provide the expected EPS growth for BOC stock?

The Earnings per Share (EPS) of BOSTON OMAHA CORP-CL A (BOC) is expected to decline by -430.25% in the next year.

BOSTON OMAHA CORP-CL A (BOC) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

BOSTON OMAHA CORP-CL A / BOC FAQ

What is the ChartMill fundamental rating of BOSTON OMAHA CORP-CL A (BOC) stock?

What is the valuation status for BOC stock?

What is the profitability of BOC stock?

Can you provide the expected EPS growth for BOC stock?